Gossamer Bio, Inc. (GOSS)
0.5217
-0.06
(-10.05%)
USD |
NASDAQ |
Mar 05, 16:00
0.52
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Free Cash Flow : -158.51M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -110.44M |
| Madrigal Pharmaceuticals, Inc. | -193.02M |
| XOMA Royalty Corp. | -15.89M |
| Rezolute, Inc. | -77.15M |
| Axsome Therapeutics, Inc. | -93.88M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -36.17M |
| Cash from Investing (Quarterly) | 17.01M |
| Cash from Financing (Quarterly) | 1.872M |
| Free Cash Flow Per Share (Quarterly) | -0.1586 |
| Free Cash Flow to Equity (Quarterly) | -36.21M |
| Free Cash Flow to Firm (Quarterly) | -33.42M |
| Free Cash Flow Yield | -133.7% |